Fund performance

 

Returns

All data as at 31 December 2025

  1 m 3 m YTD 1 y 3 y
(p.a)
5 y
(p.a)
10 y
(p.a)
Since inception
(p.a)
Bid-Bid 0.2% 3.0% 25.2% 25.2% -0.9% -8.6% - 1.8%
Offer-Bid -4.8% -2.2% 19.0% 19.0% -2.6% -9.5% - 1.1%
Benchmark 3.9% 2.2% 26.5% 26.5% 6.9% -0.9% - 4.2%

(p.a.): per annum. Source: Eastspring Investments (Singapore) Limited. Returns are based in share class currency and computed on bid-bid basis with net income reinvested, if any. Offer-bid is inclusive of sales charge which is subject to changes. Since inception returns for periods less than a year are not annualised. The benchmark for the hedged share classes, if any, is also calculated on a hedged basis. Calendar year returns are based on the share class performance for the year, and if the share class was incepted during a particular year, the returns shown relate to the performance of the share class since its inception to the end of that calendar year. Wef July 2018, the monthly fund and benchmark returns calculated are aligned to the last NAV date of the fund for the month. Past performance information presented is not indicative of future performance.

Fund facts

  • Asset classEquity
  • ClassA
  • Subscription methodCash
  • ISIN codeLU1969619763
  • Bloomberg tickerESCAGFA LX
  • Minimum initial investmentUSD 1000+
  • Minimum subsequent investmentUSD 100
  • Inception date 10 Apr 2019
  • Share class currencyUSD
  • Initial sales chargeMax 5%
  • Annual management fees1.50%
  • Benchmark indexMSCI China A Index USD
  • Morningstar rating *
    31 Dec 2025

Footnote: + Subject to Distributor's terms and conditions.
*Rating should not be taken as recommendation. © 2026 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

in insights

Know more
China: Awaiting the catalysts

in insights

Equity

China: Awaiting the catalysts

The worst of the Chinese economy appears to be behind us, but the road ahead remains bumpy.

Taking the long view on China A equities

in insights

Equity

Taking the long view on China A equities

Given China’s new growth priorities, there are opportunities for investors who ...

Going premium: Lessons from China’s beer industry

in insights

Equity

Going premium: Lessons from China’s beer industry

Rising disposable income and an increasing appreciation for quality have changed ...

Investing in Chinese tech companies through an ESG lens

in insights

Equity

Investing in Chinese tech companies through an ESG lens

Tech can help to enable ESG but the often-disruptive nature of new technologies makes ...

China: Digitalisation hastens the healthtech boom

in insights

Multi asset

China: Digitalisation hastens the healthtech boom

Changing demographics, rising affluence, lifestyle diseases and growing health ...

China : 3 trends driving the food and beverage industry

in insights

Equity

China : 3 trends driving the food and beverage industry

As China pursues its “dual circulation” growth strategy in the coming ...

China: Spotting niche opportunities in the electric vehicle industry

in insights

Equity

China: Spotting niche opportunities in the electric vehicle industry

Improving technology, growing environmental concerns and supportive government ...

Six questions on China

in insights

Equity

Six questions on China

Michelle Qi, Head of Equity at Eastspring Shanghai explains why active managers are ...

China: Advancing manufacturing for a new era

in insights

Equity

China: Advancing manufacturing for a new era

China’s entrepreneurial culture, large end market and robust supply-chain are ...

China: Uncovering opportunities within the medical beauty industry

in insights

Equity

China: Uncovering opportunities within the medical beauty industry

China is poised to become the world’s largest medical aesthetic service market ...

China: Navigating a policy driven market

in insights

Equity

China: Navigating a policy driven market

An understanding of China’s policy leanings is key to investing in its stock ...

What would be the impact of China’s digital currency?

in insights

Equity

What would be the impact of China’s digital currency?

China’s digital currency project is possibly the world’s most advanced. ...